Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9824989rdf:typepubmed:Citationlld:pubmed
pubmed-article:9824989lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:9824989lifeskim:mentionsumls-concept:C0011849lld:lifeskim
pubmed-article:9824989lifeskim:mentionsumls-concept:C0001617lld:lifeskim
pubmed-article:9824989lifeskim:mentionsumls-concept:C0009566lld:lifeskim
pubmed-article:9824989lifeskim:mentionsumls-concept:C2745955lld:lifeskim
pubmed-article:9824989lifeskim:mentionsumls-concept:C0543697lld:lifeskim
pubmed-article:9824989lifeskim:mentionsumls-concept:C0332183lld:lifeskim
pubmed-article:9824989pubmed:issue7-8lld:pubmed
pubmed-article:9824989pubmed:dateCreated1998-12-17lld:pubmed
pubmed-article:9824989pubmed:abstractTextThe hepatitis C virus (HCV) infection is characterized by a variety of extra-hepatic manifestations in many individuals. Among these, diabetes mellitus (DM) can be included, as such a metabolic disorder has been demonstrated to be more frequent in chronic hepatitis C than in liver disease due to other causes. Recently, we have observed that most patients affected with HCV-associated mixed cryoglobulinemia (13 out of 15, 86.7%), that were at baseline normoglycemic, developed DM following corticosteroid treatment (prednisone > 25 mg/daily) for at least three months. Conversely, when we consider a control group including 36 HCV negative patients affected with various immunomediated disorders, i.e., systemic lupus erythematosus, myasthenia gravis, poly/dermatomyositis and chronic inflammatory demyelinating polyneuropathy, that were initially normoglycemic, corticosteroid induced DM (prednisone > 25 mg/daily for at least three months) occurred only in 16.7% of subjects. Moreover, in other two HCV positive patients suffering from myasthenia gravis, prolonged corticosteroid treatment was complicated by DM. These data, that are still unclear from a pathophysiologic viewpoint, seem to indicate corticosteroid induced DM as a further, unusual extra-hepatic manifestation of the HCV infection.lld:pubmed
pubmed-article:9824989pubmed:languageitalld:pubmed
pubmed-article:9824989pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824989pubmed:citationSubsetIMlld:pubmed
pubmed-article:9824989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824989pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824989pubmed:statusMEDLINElld:pubmed
pubmed-article:9824989pubmed:issn0026-4806lld:pubmed
pubmed-article:9824989pubmed:authorpubmed-author:MaraiLLlld:pubmed
pubmed-article:9824989pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:9824989pubmed:authorpubmed-author:MarsonPPlld:pubmed
pubmed-article:9824989pubmed:authorpubmed-author:FaggianDDlld:pubmed
pubmed-article:9824989pubmed:issnTypePrintlld:pubmed
pubmed-article:9824989pubmed:volume89lld:pubmed
pubmed-article:9824989pubmed:ownerNLMlld:pubmed
pubmed-article:9824989pubmed:authorsCompleteYlld:pubmed
pubmed-article:9824989pubmed:pagination277-81lld:pubmed
pubmed-article:9824989pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9824989pubmed:meshHeadingpubmed-meshheading:9824989-...lld:pubmed
pubmed-article:9824989pubmed:meshHeadingpubmed-meshheading:9824989-...lld:pubmed
pubmed-article:9824989pubmed:meshHeadingpubmed-meshheading:9824989-...lld:pubmed
pubmed-article:9824989pubmed:meshHeadingpubmed-meshheading:9824989-...lld:pubmed
pubmed-article:9824989pubmed:meshHeadingpubmed-meshheading:9824989-...lld:pubmed
pubmed-article:9824989pubmed:meshHeadingpubmed-meshheading:9824989-...lld:pubmed
pubmed-article:9824989pubmed:meshHeadingpubmed-meshheading:9824989-...lld:pubmed
pubmed-article:9824989pubmed:meshHeadingpubmed-meshheading:9824989-...lld:pubmed
pubmed-article:9824989pubmed:meshHeadingpubmed-meshheading:9824989-...lld:pubmed
pubmed-article:9824989pubmed:meshHeadingpubmed-meshheading:9824989-...lld:pubmed
pubmed-article:9824989pubmed:meshHeadingpubmed-meshheading:9824989-...lld:pubmed
pubmed-article:9824989pubmed:articleTitle[Frequent occurrence of diabetes mellitus after corticosteroid treatment in mixed cryoglobulinemia. An HCV-related complication?].lld:pubmed
pubmed-article:9824989pubmed:affiliationServizio di Immunoematologia e Trasfusionale Modulo di Emocitoaferesi, Azienda Ospedaliera, Padova.lld:pubmed
pubmed-article:9824989pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9824989pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:9824989pubmed:publicationTypeReviewlld:pubmed